This document discusses formulation development of semisolid dosage forms. It begins by defining semisolid dosage forms as dermatological preparations intended for external application on the skin to produce local or systemic effects. Examples include ointments, creams, pastes and gels. Ideal properties of semisolids are discussed relating to physical, application and physiological characteristics. Common semisolid bases and preparation methods are outlined. Equipment used in the production of semisolids like homogenizers and colloidal mills are also described.
Tablets are solid dosage forms usually obtained by single or multiple compression of powders or granules. In certain cases tablets may be obtained by molding or extrusion techniques. They are uncoated or coated. Tablets are normally right circular solid cylinders, the end surfaces of which are flat or convex and the edges of which may be bevelled. They may have lines or break-marks (scoring), symbols or other markings.Tablets contain one or more active ingredients. They may contain excipients such as diluents, binders, disintegrating agents, glidants, lubricants, substances capable of modifying the behaviour of the dosage forms and the active ingredient(s) in the gastrointestinal tract, colouring matter authorized by the appropriate national or regional authority and flavouring substances. When such excipients are used it is necessary to ensure that they do not adversely affect the stability, dissolution rate, bioavailability, safety or efficacy of the active ingredient(s); there must be no incompatibility between any of the components of the dosage form.
Tablets are single-dose preparations intended for oral administration. Some are intended to be swallowed whole, some after being chewed and some after being crushed, some are intended to be dissolved or dispersed in water before being taken and some are intended to be retained in the mouth where the active ingredient(s) is/are liberated.
Tablets are solid dosage forms usually obtained by single or multiple compression of powders or granules. In certain cases tablets may be obtained by molding or extrusion techniques. They are uncoated or coated. Tablets are normally right circular solid cylinders, the end surfaces of which are flat or convex and the edges of which may be bevelled. They may have lines or break-marks (scoring), symbols or other markings.Tablets contain one or more active ingredients. They may contain excipients such as diluents, binders, disintegrating agents, glidants, lubricants, substances capable of modifying the behaviour of the dosage forms and the active ingredient(s) in the gastrointestinal tract, colouring matter authorized by the appropriate national or regional authority and flavouring substances. When such excipients are used it is necessary to ensure that they do not adversely affect the stability, dissolution rate, bioavailability, safety or efficacy of the active ingredient(s); there must be no incompatibility between any of the components of the dosage form.
Tablets are single-dose preparations intended for oral administration. Some are intended to be swallowed whole, some after being chewed and some after being crushed, some are intended to be dissolved or dispersed in water before being taken and some are intended to be retained in the mouth where the active ingredient(s) is/are liberated.
A detailed study on every aspects of parenteral :- introduction, preformulation factors, essential requirements, vehicles and additives, isotonicity, production procedure, facilities, and controls, container and closure selection and finally the quality control evaluation of parenterals.
Aerosol , components for aerosol formulation by mariomakhter@yahoo.commariomS7
Aerosol are the products that depend on the power of a compressed or liquefied gas to expel the contents from the container. Aerosols are termed also pressurized package.
A detailed study on every aspects of parenteral :- introduction, preformulation factors, essential requirements, vehicles and additives, isotonicity, production procedure, facilities, and controls, container and closure selection and finally the quality control evaluation of parenterals.
Aerosol , components for aerosol formulation by mariomakhter@yahoo.commariomS7
Aerosol are the products that depend on the power of a compressed or liquefied gas to expel the contents from the container. Aerosols are termed also pressurized package.
Boils is a painful and inflamed pus like swellings that may become chronic if remain untreated. Here available full information about boils cause, prevention and natural solution for treatment for boils.
http://www.optimumdiabeticsreview.org
Flawless skin is everyone's dream. To achieve that we need to have basic understanding of the skin structure and our own skin type, then choose the right skin care product, and continuous using it for a period of time.
Having the right attitude in taking care of our skin is very important. Here we have the basic understanding of the skin structure, to briefly explain what is function of our skin.
A suppository is a drug delivery system that is inserted into the rectum (rectal suppository), vagina (vaginal suppository) or urethra (urethral suppository), where it dissolves or melts and is absorbed into the blood stream. They are used to deliver both systemically and locally acting medications.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Semi Solid Preprations
1. F O R M U L A T I O N D E V E L O P M E N T O F S E M I S O L I D D O S A G E
F O R M S
PRESENTED BY:
Thet-ul-wafa Maqsood
Baqai institute of pharmaceutical Sciences
Baqai medical university
3. SEMISOLID DOSAGE
FORMS
Definition:
Semisolid dosage forms are dermatological preparations
intended to apply externally on the skin to produce local or
systemic effect.
Ex: Ointments, creams, pastes, gels etc
4. SEMISOLID DOSAGE
FORMS
IDEAL PROPERTIES OF SEMISOLIDS:
o PHYSICAL PROPERTIES
o APPLICATION PROPERTIES
o PHYSIOLOGICAL PROPERTIES
5. SEMISOLID DOSAGE
FORMS
PHYSICAL PROPERTIES
o Smooth texture
o Non dehydrating
o Non gritty and non greasy
o Elegant in appearance
6. SEMISOLID DOSAGE
FORMS
PHYSIOLOGICAL PROPERTIES
o Non irritating
o Do not alter membrane or skin
functioning
o Miscible with skin secretion
7. SEMISOLID DOSAGE
FORMS
APPLICATION PROPERTIES:
o Easily applicable with efficient
drug release.
o High aqueous wash ability.
8. SEMISOLID DOSAGE
FORMS
Types of semisolid bases:
The ointment base is the substance or part of ointment, which
serves as carrier or vehicle for the medicament. bases are of
following types.
9. SEMISOLID DOSAGE
FORMS
A) Oleaginous bases or Hydrocarbon base
Ex. Hard paraffin, Yellow soft paraffin.
B) Absorbent base
Ex. Hydrous wool fat, lanolin
C) Emulsion bases or water miscible bases
D) Water soluble bases
Ex. PEG, Polysorbate
11. SEMISOLID DOSAGE
FORMS
Equipments used are:
o Homogenizer
o Collide Mill
o Filling equipment
o Packaging operation.
12. SEMISOLID DOSAGE
FORMS
HOMOGENIZERS:
For homogenization colloidal mill is
used.
Colloidal mill:
It consists of two steel discs one is
stationary and other is rotating.when
the material is passed through these
discs they get sheared. Thus,coarse
particles are broken down to small
particles due to shear.
Uses:
Used for preparation of
suspensions,ointments.
Advantage :
It can be easily sterilised.
Disadvantage:
Heat is generated during milling.
13. SEMISOLID DOSAGE
FORMS
Fusion method:
Anhydrous ointments are prepared by fusion
method.
Active substances is dissolved in the melted fats
and waxes and then mixed with base. The melted
mass must mixed while cooling because the fatty
alcohols, fatty acids, and waxes do not form true
solutions, but crystallize from the melt as the
temperature falls.
14. SEMISOLID DOSAGE
FORMS
Homogenization frequently increases the consistency of a
semisolid emulsion because it increases the number of emulsified
particles.
consistency is affected by
1. Number of passes through the homogenizer.
2. Pressures used for homogenization.
15. SEMISOLID DOSAGE
FORMS
Aeration should be avoided, since it may lead to emulsion instability
and variation in density.
Aeration maybe prevented at the primary emulsion step if one phase
is introduced into the other in such a manner that splashing and
streaming are avoided.
Splashing can overcome by careful adjustment of the mixing
conditions and liquid flow pattern.
Completely enclosed kettles are available for the manufacturing of
semisolids which tend to aerate excessively.
16. SEMISOLID DOSAGE
FORMS
Manufacture of emulsified semisolids:
Time, temperature and mechanical work are the three variables in the
manufacture of emulsified semisolids. The three factors are interrelated and must
be carefully controlled if the same high quality batches are to manufactured.
Equipment is available for automatically controlling many aspects of
emulsion manufacture, such as the complete control of the temperature in the jacket
and regulation of the mixing time and rate of agitation
18. PREPARATION
(Oil Phase)
The components of the oil mixtures are placed into a stainless steel
steam jacketed kettle, melted and mixed.
Some of the solid components e.g. stearic acid, cetyl alchol are
available in many different forms like cakes, flakes or powder. The
flakes are more preferable because of the convenience of handling.
Petrolatum (a Hydrocarbon base) is inconvenient to handle unless it
is melted and transferred by pumping or pouring from its drum.
19. PREPARATION
The oil phase is then strained through several layers of
cheese cloth to remove any foreign matter.
If petrolatum is used as oil phase then it should be passed
through filter medium particularly in ophthalmic
preparations.
The oil phase is transferred by gravity or pump to the
emulsion mixing kettle.
20. PREPARATION
(Aquous Phase)
The components of the aqueous phase are dissolved in the
purified water and filtered.
A soluble drug may be added to this aqueous phase.
22. MIXING
The phases are usually mixed at a temperature of 70 to
720C,because at this temperature intimate mixing of the liquid
phases can occur.
The properties of some emulsions depend on the temperature at
which the phases are mixed. The initial mixing temperature must
be raised above 70 to 72 0C.
23. MIXING
Equipments used for mixing of phases:
Agitator mixers :
Sigma mixer and planetary mixer.
Shear mixers:
Triple roller mill and Colloidal mill.
24. COOLING
COOLING THE SEMISOLID EMULSION:
The rate of cooling is generally slow to allow for adequate mixing
while the emulsion is still liquid.
The temperature of the cooling medium in the equipment should
be decreased gradually and at a rate consistent with the mixing of
the emulsion and scrapping of the kettle walls to prevent formation
of congealed masses of the ointment or cream.
25. GELS
Includes in semi solid preparation but It is normally formulated as a suspension.
26. WHAT IS GEL?
Pharmaceutical gels are semisolid systems in which there is interaction (either
physical or covalent) between colloidal particles within a liquid vehicle.
OR
A 3D matrics system In which the Active Pharmaceutical Ingredient is invaded.
The vehicle may be:
Aqueous
Hydroalcoholic
Alcohol based Or
Non Aqueous
27. PHARMACEUTICAL CONS IDERATION OF
PHARMACEUTICAL GELS
Includes:
Choice of vehicles
Inclusion of buffers
Preservatives
Antioxidants
Flavoring and coloring agents
28. GELLING AGENT
These are substances which, when added to an aqueous mixture,
increase its viscosity without substantially modifying its other properties,
such as taste. They provide body, increase stability, and improve
suspension of added ingredient.
Ex. Ethylcellulose , hydroxypropyl cellulose etc.
30. 1 . NATURAL POLYMERS
Tragacanth Geletin
• Obtained from Collagin (in
plants).
• Biocompatable .
• Can be used in parentrales.
• Should be soaked over
night.
• Forms clumps in water.
• Glycerin and propylene
glycol should be used as a
humectant.
31. 2 . SEMI SYNTHETIC POLYMERS
Carboxymethylcellulose. Methylcellulose.
Used in the conc. Of 4-6%
Insoluble in water.
Also use as viscosity Enhancers.
Used in the conc. Of 5%
Ethylene and propylene glycol
should be used as a humectant.
32. 3 . SYNTHETIC POLYMERS
An acrylic based polymer.
Used in the conc. Of 0.5-1%
Also used as thickning and suspending agent.
34. PREPARATION OF GELS
Water
Preser
vative
• Gelling
agent
Soake
Over
night
Add
Glycerine
With
propylene
glycol
mixed with
API
And then
make up
the
volume
35. DURATION OF SWELLING
A swelling duration of about 24 – 48 hours generally helps in
obtaining homogeneous gels.
Natural gums need about 24 hours.
cellulose polymers require about 48 hours for complete
hydration.
36. A person who Never made a mistake never tried any thing
new…
“Albert Einstein”
Thanks For Sharing This Time….